Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.

Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH.

Semin Thromb Hemost. 2000;26(3):335-40. Review.

PMID:
11011851
[PubMed - indexed for MEDLINE]
2.

[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].

Guilland JC, Favier A, Potier de Courcy G, Galan P, Hercberg S.

Pathol Biol (Paris). 2003 Mar;51(2):101-10. Review. French.

PMID:
12801808
[PubMed - indexed for MEDLINE]
3.

Homocysteine, coagulation, platelet function, and thrombosis.

Coppola A, Davi G, De Stefano V, Mancini FP, Cerbone AM, Di Minno G.

Semin Thromb Hemost. 2000;26(3):243-54. Review.

PMID:
11011842
[PubMed - indexed for MEDLINE]
4.

B vitamins and homocysteine in cardiovascular disease and aging.

Wilcken DE, Wilcken B.

Ann N Y Acad Sci. 1998 Nov 20;854:361-70. Review.

PMID:
9928444
[PubMed - indexed for MEDLINE]
5.

Hyperhomocysteinemia, atherosclerosis and thrombosis.

Cattaneo M.

Thromb Haemost. 1999 Feb;81(2):165-76. Review.

PMID:
10063987
[PubMed - indexed for MEDLINE]
6.

Classical homocystinuria: vascular risk and its prevention.

Yap S.

J Inherit Metab Dis. 2003;26(2-3):259-65. Review.

PMID:
12889665
[PubMed - indexed for MEDLINE]
7.

Homocysteine and renal disease.

van Guldener C, Robinson K.

Semin Thromb Hemost. 2000;26(3):313-24. Review.

PMID:
11011849
[PubMed - indexed for MEDLINE]
8.

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6.

PMID:
14656016
[PubMed - indexed for MEDLINE]
9.

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.

Clarke R, Armitage J.

Semin Thromb Hemost. 2000;26(3):341-8. Review.

PMID:
11011852
[PubMed - indexed for MEDLINE]
10.

[Homocysteine and cardiovascular risk].

Lutteri L, Chapelle JP, Gielen J.

Rev Med Liege. 1999 Jun;54(6):541-7. Review. French.

PMID:
10446525
[PubMed - indexed for MEDLINE]
11.

Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.

Boers GH.

Neth J Med. 1994 Jul;45(1):34-41. Review.

PMID:
8065483
[PubMed - indexed for MEDLINE]
12.

Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia.

O'Donnell J, Perry DJ.

Expert Opin Pharmacother. 2002 Nov;3(11):1591-8. Review.

PMID:
12437493
[PubMed - indexed for MEDLINE]
13.

Does lowering plasma homocysteine reduce vascular disease risk?

Miller JW.

Nutr Rev. 2001 Jul;59(7):242-4. Review.

PMID:
11475450
[PubMed - indexed for MEDLINE]
14.

[Present role of homocysteine in clinical medicine].

Aguirre Errasti C, Egurbide Arberas MV, Martínez Berriotxoa A.

Med Clin (Barc). 2009 Oct 3;133(12):472-8. doi: 10.1016/j.medcli.2008.11.032. Epub 2009 Apr 8. Review. Spanish.

PMID:
19359001
[PubMed - indexed for MEDLINE]
15.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
[PubMed - indexed for MEDLINE]
16.

[From gene to disease; from homocysteine to hyperhomocysteinemia].

Boers GH.

Ned Tijdschr Geneeskd. 2001 May 19;145(20):956-8. Review. Dutch.

PMID:
11396261
[PubMed - indexed for MEDLINE]
17.

Hyperhomocysteinemia: an additional cardiovascular risk factor.

Fanapour PC, Yug B, Kochar MS.

WMJ. 1999 Dec;98(8):51-4. Review.

PMID:
10639897
[PubMed - indexed for MEDLINE]
18.

Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment.

Brattström L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A.

Atherosclerosis. 1990 Feb;81(1):51-60. Review.

PMID:
2407253
[PubMed - indexed for MEDLINE]
19.

Genetic modulation of homocysteinemia.

Rozen R.

Semin Thromb Hemost. 2000;26(3):255-61. Review.

PMID:
11011843
[PubMed - indexed for MEDLINE]
20.

[Risk factors for cardiovascular diseases: what is the role for homocysteine?].

Bendini MG, Lanza GA, Mazza A, Giordano A, Leggio M, Menichini G, De Cristofaro R, Moriconi E, Cozzari L, Farina SM, Giordano G.

G Ital Cardiol (Rome). 2007 Mar;8(3):148-60. Review. Italian.

PMID:
17461357
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk